Yale BioHaven Entrepreneurship Seminars Present Marinus Pharmaceuticals: "Reformulating for Successful Drug Development"

The Yale BioHaven Entrepreneurship Seminars series continues its spring schedule on Wednesday, February 7, featuring Marinus Pharmaceuticals, Inc. (Marinus), a new specialty pharmaceutical company dedicated to the development and commercialization of novel drugs to treat serious neurological, psychiatric, and pain disorders. The program will be held from 4 to 5 p.m. in the Anlyan Center Auditorium of Yale Medical School, 300 Cedar Street. Registration will begin at 3:30 p.m.

The Yale BioHaven Entrepreneurship Seminars series continues its spring schedule on Wednesday, February 7, featuring Marinus Pharmaceuticals, Inc. (Marinus), a new specialty pharmaceutical company dedicated to the development and commercialization of novel drugs to treat serious neurological, psychiatric, and pain disorders.

The program will be held from 4 to 5 p.m. in the Anlyan Center Auditorium of Yale Medical School, 300 Cedar Street. Registration will begin at 3:30 p.m.

Speakers are the Chairman and CEO of Marinus, Harry H. Penner, Jr., and the Founding Discovery Officer of Marinus, Vincent Pieribone, who is also an associate professor of physiology, Yale University. A primary focus of their presentation will be the company’s formation.

Marinus is developing Ganaxolone for the treatment of epilepsy. Utilizing proprietary technologies, Marinus successfully reformulated this promising new drug, and Phase IIb clinical trials are expected to begin soon. Marinus has licensed another compound, Chelerythrine, from Yale University and it is in pre-clinical development to target both the treatment of bipolar disorder and the cognitive deficits of schizophrenia.

Marinus has received funding from the Epilepsy Project, Stanley Medical Research Foundation, Connecticut Innovations and the National Institutes of Health, and in October 2005, the company announced the closing of a $29.4 million Series A financing round led by venture funding and private investors.

Refreshments and networking will follow the seminar from 5 to 6 p.m. Registration is free, but advance RSVP to Larry Banks at larry.banks@yale.edu or the Yale Office of Cooperative Research at 203-436-8096 is required. Directions to the event are available on line at http://info.med.yale.edu/maps/cab.html.

Yale BioHaven Entrepreneurship Seminars are sponsored by the Yale Office of Cooperative Research and Connecticut United for Research Excellence (CURE), and jointly promoted by Yale Entrepreneurial Society (YES) andYale Biotechnology & Pharmaceutical Societyy (YBPS). For further information on the seminar, please contact Tracy Huang at 203-785-3846 or tracy.huang@yale.edu.

Share this with Facebook Share this with X Share this with LinkedIn Share this with Email Print this

Media Contact

Janet Rettig Emanuel: janet.emanuel@yale.edu, 203-432-2157